A single amino acid substitution in the S1 and S2 Spike protein domains determines the neutralization escape phenotype of SARS-CoV. (Q40073664)

17 September 2017

A single amino acid substitution in the S1 and S2 Spike protein domains determines the neutralization escape phenotype of SARS-CoV. (English)

1 reference

17 September 2017

0 references

1 reference

9

Naoki Yamamoto

1 reference

17 September 2017

Yu-ya Mitsuki

1

1 reference

17 September 2017

Kazuo Ohnishi

2

1 reference

17 September 2017

Hirotaka Takagi

3

1 reference

17 September 2017

Masamichi Oshima

4

1 reference

17 September 2017

Takuya Yamamoto

5

1 reference

17 September 2017

Fuminori Mizukoshi

6

1 reference

17 September 2017

Kazutaka Terahara

7

1 reference

17 September 2017

Kazuo Kobayashi

8

1 reference

17 September 2017

Shoji Yamaoka

10

1 reference

17 September 2017

Yasuko Tsunetsugu-Yokota

11

1 reference

17 September 2017

19 June 2008

1 reference

17 September 2017

Microbes and Infection

1 reference

17 September 2017

10

1 reference

17 September 2017

8

1 reference

17 September 2017

908-915

1 reference

Immunological detection of severe acute respiratory syndrome coronavirus by monoclonal antibodies.

17 September 2017

1 reference

12 December 2020

Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines

1 reference

12 December 2020

Single amino acid substitutions in the severe acute respiratory syndrome coronavirus spike glycoprotein determine viral entry and immunogenicity of a major neutralizing domain.

1 reference

12 December 2020

Identification and characterization of the putative fusion peptide of the severe acute respiratory syndrome-associated coronavirus spike protein

1 reference

12 December 2020

Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies

1 reference

12 December 2020

Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors

1 reference

12 December 2020

Structure of SARS coronavirus spike receptor-binding domain complexed with receptor

1 reference

12 December 2020

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

1 reference

12 December 2020

Profile of specific antibodies to the SARS-associated coronavirus.

1 reference

12 December 2020

Generation and characterization of human monoclonal neutralizing antibodies with distinct binding and sequence features against SARS coronavirus using XenoMouse

1 reference

12 December 2020

Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association

1 reference

12 December 2020

Characterization of neutralizing monoclonal antibodies recognizing a 15-residues epitope on the spike protein HR2 region of severe acute respiratory syndrome coronavirus (SARS-CoV).

1 reference

12 December 2020

SARS: what have we learned?

1 reference

12 December 2020

Severe acute respiratory syndrome (SARS) coronavirus: application of monoclonal antibodies and development of an effective vaccine

1 reference

12 December 2020

A single amino acid change within antigenic domain II of the spike protein of bovine coronavirus confers resistance to virus neutralization

1 reference

12 December 2020

A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice.

1 reference

12 December 2020

Monoclonal antibodies targeting the HR2 domain and the region immediately upstream of the HR2 of the S protein neutralize in vitro infection of severe acute respiratory syndrome coronavirus.

1 reference

12 December 2020

Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1.

1 reference

12 December 2020

Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region.

1 reference

12 December 2020

A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2

1 reference

12 December 2020

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

1 reference

12 December 2020

Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice

1 reference

12 December 2020

Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies

1 reference

12 December 2020

Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants

1 reference

12 December 2020

Induction of protective immunity against severe acute respiratory syndrome coronavirus (SARS-CoV) infection using highly attenuated recombinant vaccinia virus DIs.

1 reference

12 December 2020

B-cell responses in patients who have recovered from severe acute respiratory syndrome target a dominant site in the S2 domain of the surface spike glycoprotein

1 reference

12 December 2020

Identifying epitopes responsible for neutralizing antibody and DC-SIGN binding on the spike glycoprotein of the severe acute respiratory syndrome coronavirus

1 reference

12 December 2020

Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge

1 reference

12 December 2020

10.1016/J.MICINF.2008.05.009

Identifiers

DOI

1 reference

17 September 2017

0 references

1 reference